4//SEC Filing
MacDonald Brian Richard 4
Accession 0000950170-23-031207
CIK 0001816736other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:29 PM ET
Size
22.5 KB
Accession
0000950170-23-031207
Insider Transaction Report
Form 4
MacDonald Brian Richard
Chief Innovation Officer
Transactions
- Sale
Common Stock
2023-06-28$49.24/sh−2,247$110,649→ 25,153 total - Sale
Common Stock
2023-06-28$50.80/sh−953$48,415→ 22,300 total - Sale
Common Stock
2023-06-29$45.49/sh−2,230$101,453→ 19,334 total - Sale
Common Stock
2023-06-29$46.51/sh−1,934$89,952→ 17,400 total - Sale
Common Stock
2023-06-30$46.76/sh+600$28,058→ 12,276 total - Sale
Common Stock
2023-06-29$44.37/sh−736$32,656→ 21,564 total - Sale
Common Stock
2023-06-28$50.38/sh−1,900$95,730→ 23,253 total - Sale
Common Stock
2023-06-29$47.24/sh−200$9,448→ 17,200 total - Sale
Common Stock
2023-06-30$44.85/sh−2,923$131,102→ 14,277 total - Sale
Common Stock
2023-06-30$45.45/sh−1,401$63,676→ 12,876 total
Holdings
- 1,096(indirect: Held by Son)
Common Stock
- 1,096(indirect: Held by Son)
Common Stock
- 1,096(indirect: Held by Son)
Common Stock
Footnotes (12)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 17, 2023.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.31 to $45.58, inclusiv
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.56 to $47.00, inclusive.
- [F12]The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.61 to $49.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.61 to $50.59, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.235, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.87, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.94, inclusive.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.96, inclusive.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.25, inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.29, inclusive.
Documents
Issuer
Disc Medicine, Inc.
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001952556
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:29 PM ET
- Size
- 22.5 KB